Loading patent…
AssigneeCadila Healthcare Limited
InventorsMukul R. Jain, Suresh Giri, Himanshu M. Kothari, Kaushik Banerjee, Rashmikant Kachhiya
Estimating the term…
The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase IV (DPP IV) inhibitor or one or more biguanide antihyperglycaemic agent and a PPAR agonist of formula (Ia) for the treatment of diabetes, especially non-insulin dependent diabetes (NIDDM) or Type 2 diabetes and conditions associated with diabetes mellitus and to compositions suitable for use in such method. The invention also describes the preparation of such compositions. The present invention also relates to certain novel salts of the PPAR agonist of formula (I), processes for the preparation of these novel salts and use thereof.
A synergistic composition comprising a compound of formula I(a)
A method for the treatment of dyslipidemia, hypertriglyceridemia and diabetes mellitus comprising administering an effective, non-toxic and pharmaceutically acceptable amount of a compound of formula I(a)
A pharmaceutical composition comprising a compound of formula I(a)
Dependencies are inferred from the claim text.